BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marchianò S, Biagioli M, Roselli R, Zampella A, Di Giorgio C, Bordoni M, Bellini R, Urbani G, Morretta E, Monti MC, Distrutti E, Fiorucci S. Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling. Biochim Biophys Acta Mol Cell Biol Lipids 2022;1867:159218. [PMID: 35985473 DOI: 10.1016/j.bbalip.2022.159218] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Marchianò S, Biagioli M, Morretta E, Di Giorgio C, Roselli R, Bordoni M, Bellini R, Urbani G, Massa C, Monti MC, Zampella A, Distrutti E, Fiorucci S. Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH. Sci Rep 2023;13:1602. [PMID: 36709356 DOI: 10.1038/s41598-023-28647-4] [Reference Citation Analysis]
2 Fang J, Yu C, Li X, Yao J, Fang Z, Yoon S, Yu W. Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.997018] [Reference Citation Analysis]